Aberdeen Asia Pacific (ex-Japan) Equity Fund HKSE:02269 Holdings History
Aberdeen Asia Pacific (ex-Japan) Equity Fund's WuXi Biologics (Cayman) Inc Holding Summary
As of 2021-01-31, Aberdeen Funds held 13,500.00 shares of WuXi Biologics (Cayman) Inc(HKSE:02269), totaling HK$189,030.00. This investment constitutes 2.56% of their stock portfolio, and Aberdeen Funds now holds 0% of the outstanding WuXi Biologics (Cayman) Inc(HKSE:02269) stock.
The initial trade took place in 2019Q4. In addition, there have been 2 sales at an average price of HK$50.20 for 6,000.00 shares. Based on historical transaction data and HKSE:02269's current price of HK$28.00, Aberdeen Asia Pacific (ex-Japan) Equity Fund's estimated gain on his HKSE:02269 holdings is HK$150,915.00, reflecting a 28.57% gain to date.
Aberdeen Asia Pacific (ex-Japan) Equity Fund HKSE:02269 (HK$28.00) Holding Chart
Aberdeen Asia Pacific (ex-Japan) Equity Fund HKSE:02269 (HK$28.00) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price HK$-/Share | ||
| Shares Sold | 0 | Average Price HK$-/Share | ||
| Current Price HK$0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
